CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Reconciliation of net income (loss) to cash used by operating activities:
Net income (loss)	$ 7,374	$ (4,784)
Add (deduct):
Depreciation and amortization	4,231	5,990
Provision for bad debt	154	446
Net realized and unrealized losses (gains)	11,091	(3,403)
Amortization of net premium on debt securities investments	1,144	1,353
Payments for title losses in excess of provisions	(2,809)	(7,781)
Adjustment for insurance recoveries of title losses	173	380
Decrease (increase) in receivables – net	11,542	(5,686)
Increase in other assets – net	(3,813)	(815)
Decrease in accounts payable and other liabilities – net	(43,165)	(26,212)
Change in net deferred income taxes	1,495	(252)
Net income from equity investees	(645)	(374)
Dividends received from equity investees	1,235	353
Stock-based compensation expense	887	804
Other – net	(254)	98
Cash used by operating activities	(11,360)	(39,883)
Investing activities:
Proceeds from sales of investments in securities	11,796	6,958
Proceeds from matured investments in debt securities	18,814	20,094
Purchases of investments in securities	(30,703)	(561)
Net sales (purchases) of short-term investments	2,982	(456)
Purchases of property and equipment, and real estate – net	(4,781)	(2,735)
Cash paid for acquisition of businesses	(1,449)	0
Other – net	38	1,287
Cash (used) provided by investing activities	(3,303)	24,587
Financing activities:
Payments on notes payable	(8,223)	(7,446)
Proceeds from notes payable	204	4,454
Distributions to noncontrolling interests	(3,326)	(3,177)
Repurchases of common stock	(393)	(379)
Cash dividends paid	(7,099)	(7,083)
Cash used by financing activities	(18,837)	(13,631)
Effects of changes in foreign currency exchange rates	(3,510)	1,367
Decrease in cash and cash equivalents	(37,010)	(27,560)
Cash and cash equivalents at end of period	330,609	192,067
Cash and cash equivalents at end of period	$ 293,599	$ 164,507